Ciprofloxacin-induced bone marrow depression.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10616701.
- Also identified by PMC identifier 1741342.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ciprofloxacin, a broad-spectrum fluoroquinolone antibacterial agent, is generally considered to be a safe drug. However, occasionally it may have life-threatening complications. Two instances of bone marrow failure following use of ciprofloxacin are reported. In one case, the bone marrow reverted to normal following withdrawal of the drug. In the other case, the patient succumbed to irreversible bone marrow depression leading to severe thrombocytopenia and uncontrolled bleeding. This could have been an idiosyncratic reaction.
Medical subject headings
- Anti-Infective Agents
- Ciprofloxacin
- Pancytopenia